Christopher Dale Kontos
Professor of MedicineOverview
The Kontos Lab studies the molecular mechanisms of angiogenesis and vascular remodeling. Studies are directed toward understanding how signal transduction by endothelial receptor tyrosine kinase (RTKs) regulates vascular growth in both physiological and pathological processes, including exercise, peripheral artery disease (PAD), atherosclerosis, and cancer.
Current projects include:
1. Signal transduction, mechanisms of activation, and downregulation of endothelial RTKs (mainly Tie1, Tie2, VEGFR-1, and VEGFR-2)
2. Differential effects of the Angiopoietins
3. Role of the inositol phosphatase PTEN in the regulation of vascular cell growth and remodeling
4. PTEN gene therapy for prevention of vein graft disease
5. Angiogenic signaling in skeletal muscle, including mechanisms of exercise-induced angiogenesis
6. Proteolytic cleavage and shedding of endothelial RTKs
7. Angiogenic proteins as biomarkers in peripheral artery disease
Positions
Professor of Medicine in the School of Medicine
2017 School of Medicine
Director, Medical Scientist Training Program in the School of Medicine
2009 School of Medicine
Professor of Cell Biology in the School of Medicine
2022 School of Medicine
Professor of Pharmacology and Cancer Biology in the School of Medicine
2017 School of Medicine
Member of the Duke Cancer Institute in the School of Medicine
1993 School of Medicine
Education
M.D. 1989
1989 Virginia Commonwealth University
Fellow in Cardiology, Medicine
1997 Duke University
Publications, Grants & Awards
Offices & Contact
Durham, NC
27710 Duke Box 102148
Durham, NC
27710